Commonwealth Equity Services’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
367,113
+33,017
+10% +$100K ﹤0.01% 2603
2025
Q4
$1.39M Buy
334,096
+39,195
+13% +$206K ﹤0.01% 2304
2025
Q3
$1.25M Buy
294,901
+9,487
+3% +$35.7K ﹤0.01% 2418
2025
Q2
$602K Buy
285,414
+27,849
+11% +$41.7K ﹤0.01% 3000
2025
Q1
$314K Buy
257,565
+123,047
+91% +$173K ﹤0.01% 3453
2024
Q4
$174K Sell
134,518
-348,746
-72% -$836K ﹤0.01% 3803
2024
Q3
$1.33M Sell
483,264
-87
-0% -$214 ﹤0.01% 2108
2024
Q2
$1.09M Buy
483,351
+367,610
+318% +$1.12M ﹤0.01% 2215
2024
Q1
$277K Buy
115,741
+10,355
+10% +$19.6K ﹤0.01% 3347
2023
Q4
$175K Sell
105,386
-1,136
-1% -$2.2K ﹤0.01% 3559
2023
Q3
$205K Buy
106,522
+5,000
+5% +$8.23K ﹤0.01% 3361
2023
Q2
$146K Hold
101,522
﹤0.01% 3497
2023
Q1
$213 Hold
101,522
﹤0.01% 3261
2022
Q4
$114K Buy
101,522
+63,302
+166% +$84.3K ﹤0.01% 3390
2022
Q3
$62K Hold
38,220
﹤0.01% 3454
2022
Q2
$50K Buy
38,220
+11,318
+42% +$16.3K ﹤0.01% 3483
2022
Q1
$43K Buy
26,902
+10,000
+59% +$19.4K ﹤0.01% 3595
2021
Q4
$34K Buy
16,902
+5,000
+42% +$14.3K ﹤0.01% 3568
2021
Q3
$46K Buy
+11,902
New +$40.3K ﹤0.01% 3500
2019
Q4
Sell
-16,352
Closed -$60K 2912
2019
Q3
$60K Buy
16,352
+1,105
+7% +$3.99K ﹤0.01% 2727
2019
Q2
$63K Buy
15,247
+3,059
+25% +$13.2K ﹤0.01% 2679
2019
Q1
$62K Buy
12,188
+1,000
+9% +$4.8K ﹤0.01% 2650
2018
Q4
$38K Buy
+11,188
New +$53.4K ﹤0.01% 2584
2016
Q3
Sell
-29,733
Closed -$44K 2269
2016
Q2
$44K Sell
29,733
-3,250
-10% -$4.77K ﹤0.01% 2167
2016
Q1
$47K Buy
32,983
+3,385
+11% +$4.54K ﹤0.01% 2130
2015
Q4
$49K Buy
29,598
+7,350
+33% +$16.8K ﹤0.01% 2104
2015
Q3
$52K Buy
22,248
+1,250
+6% +$2.95K ﹤0.01% 2048
2015
Q2
$57K Sell
20,998
-3,600
-15% -$10.9K ﹤0.01% 2126
2015
Q1
$82K Buy
24,598
+4,450
+22% +$15.9K ﹤0.01% 2080
2014
Q4
$70K Buy
20,148
+87
+0.4% +$384 ﹤0.01% 2007
2014
Q3
$101K Buy
20,061
+3,000
+18% +$23.4K ﹤0.01% 1957
2014
Q2
$236K Buy
17,061
+1,565
+10% +$19.5K ﹤0.01% 1718
2014
Q1
$237K Buy
+15,496
New +$221K ﹤0.01% 1639

Other funds holding GALT